Tc Biopharm (Holdings) Plc盘中异动大幅拉升5.26%报0.332美元

市场透视2025-02-05

北京时间2025年02月05日00时16分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现波动，股价快速上涨5.26%。截至发稿，该股报0.332美元/股，成交量9.8441万股，换手率0.96%，振幅7.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.51百万美元，每股收益-6.06美元，毛利-152137.55美元，市盈率-0.00倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2509002466?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-05 00:16","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2509002466","market":"us","top_or_hot":-1,"title":"Tc Biopharm (Holdings) Plc盘中异动 大幅拉升5.26%报0.332美元","media":"市场透视","content":"<div>\n<p>北京时间2025年02月05日00时16分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现波动，股价快速上涨5.26%。截至发稿，该股报0.332美元/股，成交量9.8441万股，换手率0.96%，振幅7.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.51百万美元，每股收益-6.06美元，毛利-152137.55美元，市盈率-0.00倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001658a2393d55&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tc Biopharm (Holdings) Plc盘中异动 大幅拉升5.26%报0.332美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTc Biopharm (Holdings) Plc盘中异动 大幅拉升5.26%报0.332美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-05 00:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001658a2393d55&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月05日00时16分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现波动，股价快速上涨5.26%。截至发稿，该股报0.332美元/股，成交量9.8441万股，换手率0.96%，振幅7.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.51百万美元，每股收益-6.06美元，毛利-152137.55美元，市盈率-0.00倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001658a2393d55&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TCBP","symbol_name":"TC BioPharm","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001658a2393d55&s=b","article_id":"2509002466","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001658a2393d55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2509002466","pubTimestamp":1738685817,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月05日00时16分，Tc Biopharm  Plc股票出现波动，股价快速上涨5.26%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Evaxion Biotech As涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1632.71%、925.83%、469.73%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、49.88%、47.29%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"TCBP":"TC BioPharm","BK4139":"生物科技"},"translate_title":"Tc Biopharm (Holdings) Plc surged 5.26% to $0.332 after intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TCBP":0.9},"content_text":"北京时间2025年02月05日00时16分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现波动，股价快速上涨5.26%。截至发稿，该股报0.332美元/股，成交量9.8441万股，换手率0.96%，振幅7.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.51百万美元，每股收益-6.06美元，毛利-152137.55美元，市盈率-0.00倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Tc Biopharm (Holdings) Plc股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028(To Pur Com)、Evaxion Biotech As涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1632.71%、925.83%、469.73%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 (To Pur Ord)、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、49.88%、47.29%。Tc Biopharm (Holdings) Plc公司简介：TC BioPharm (Holdings) PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T（缩写为 GD-T）细胞平台的新型免疫治疗产品。 利用 GD-T 的先天能力，该公司能够开发出一系列旨在对抗癌症和病毒感染的临床阶段细胞疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2509002466","isCrawlerRequest":true}

Tc Biopharm (Holdings) Plc盘中异动 大幅拉升5.26%报0.332美元

精彩评论

Tc Biopharm (Holdings) Plc盘中异动大幅拉升5.26%报0.332美元